A drug to treat a liver disease has received its first US approval. The disease being treated is referred to as both MASH and NASH, with the approved drug being Madrigal's Rezdiffra, although another company, Novo, has also received approval for a drug called Wegovy for a similar condition. The approval is seen as significant, with other companies and treatments also being developed for the disease.